Is Shotsy worth paying for?

Shotsy runs on a freemium model with a free trial, and its App Store in-app purchase list shows several concurrent price points rather than one settled monthly and annual figure. The table below prints the tiers exactly as they appear in that list: this is Shotsy's own published data, not our characterisation of it.

Reviewers report being shown different prices depending on which path they take through onboarding, including a case where selecting the free-trial option raised the annual price compared with paying immediately. We report that as what reviewers describe experiencing, not as a claim about how the app's pricing logic works internally, because we haven't seen the code. In our view it's worth knowing before you commit: check what you're actually being offered against the published tiers, and don't assume the number on your screen is the only one in circulation.

Strip away the surrounding complaints and one feature explains most of the enthusiasm in Shotsy's reviews: the estimated medication-level chart. In our reading of the review corpus, it is the medication-level curve, not the act of logging a shot, that users actually value in this category. Reviewers describe using it to correlate side effects with where they sit in their dose cycle, to catch that they're a faster or slower responder than expected, and to bring a concise record to an appointment rather than trying to reconstruct months of history from memory.

It's worth being clear about what that chart actually is, though: an estimated medication-level curve is a model, not a measurement. How quickly a given person clears a dose depends on body weight, height, metabolism and dose history, so the same estimate can land some way off for two different people on an identical schedule. Our view is that a number presented with more precision than the underlying model supports isn't something you want to bring to a prescriber as fact, even if it's a genuinely useful pattern-finding tool day to day.

Support quality shows up repeatedly as a reason people forgive other frustrations. Reviewers have reported fast, personal replies from named staff when they raised a specific problem directly.

Export is worth calling out too. Shotsy's App Store version history documents CSV export as a shipped feature, so the record you build doesn't have to live inside the app forever; reviewers describe using it specifically to backfill and reconstruct their history from pharmacy records when they started tracking late.

The complaint that shows up most often isn't about a missing feature: it's about a feature that used to be free. Shotsy reviewers have repeatedly reported functionality that was previously available without a subscription moving behind the paywall over successive updates, and the estimated medication-level chart itself is frequently the feature named. That's a difficult thing to read for anyone weighing a renewal, because the exact capability that makes the app worth paying for is also the one some longstanding users say they had for free and then lost.

The clearest single renewal-decision quote in the review corpus is worth reading in full, and it's worth being upfront that it's a four-star review, not a one-star pile-on: the reviewer still rates the app positively while genuinely weighing whether to keep paying.

One more pattern belongs here, and it isn't unique to Shotsy: reviewers of several apps in this category, Shotsy among them, report being charged despite believing they had cancelled within a stated free-trial window. We're reporting this as a category-wide pattern with examples rather than pinning it on any single app, because the same shape of complaint (trial started, cancellation attempted, charge landed anyway) turns up in multiple competitors' review histories too. If you're renewing, or letting a renewal lapse, it's worth checking your subscription status directly in the App Store or Play Store rather than trusting the app's own cancellation flow to have registered.

The honest framework is narrower than most "is it worth it" pieces make it sound. If you're actively using the estimated-medication-level chart (adjusting timing, correlating side effects, discussing a dose change with your provider), the subscription is buying you something no free tool replicates well. If your use of the app is closer to a shot calendar and a weight line, the case for paying gets much weaker, because that job is done adequately by apps that charge nothing or next to nothing.

It's also worth knowing that testing before committing is normal, not a sign of indecision. Reviewers across this category routinely describe trying several tracking apps in a short space of time and settling on one fast, so a short trial period spent actually using the medication-level feature, rather than reading about it, is a reasonable and common way to make this call.

If a shot log and a weight chart really is the whole job, two apps are worth a look before you renew anything. GlucoPal requires no account to use at all, unusually for this category, and runs on a lower minimum iOS version than the rest of the set, so it's worth a look on an older iPhone too; reviewers describe its free tier as genuinely usable on its own, not just a taster for the paid version. Reviewers describe choosing Pokii for a similar reason: being able to use it without subscribing.

There's also a low-tech comparison worth having in mind. Long before app subscriptions, patients were tracking this by hand (spreadsheets, notebooks, wall calendars), and templates for exactly that purpose are still sold on marketplaces like Etsy as a single one-off purchase rather than a recurring subscription. It's a useful anchor for what you're actually paying an ongoing fee for: not the record-keeping itself, which a template can do, but the pattern-finding a live medication-level model does with that record.